Literature DB >> 35535063

Gallstone Disease in Cirrhosis-Pathogenesis and Management.

Bipadabhanjan Mallick1, Anil C Anand1.   

Abstract

Gallstones are more common in patients with cirrhosis of the liver, and the incidence increases with severity of liver disease. Pigment stones are the most frequent type of gallstones (GSs) in cirrhotics, and majority remain asymptomatic. Hepatitis C virus infection and nonalcoholic fatty liver disease are the underlying etiologies of liver diseases that most often associated with GSs. Multiple altered mechanisms in cirrhosis such as chronic hemolysis due to hypersplenism, reduced bile acid synthesis and transport, decreased cholesterol secretion, decreased apolipoprotein A-I and A-II secretion, gallbladder hypo-motility, autonomic dysfunction, and portal hypertension collectively lead to increased risk of lithogenesis. Asymptomatic GSs should be followed up closely and offered laparoscopic cholecystectomy once symptomatic in Child-Pugh class A and B patients. The model for the end-stage liver disease score is the best predictor of the outcome after cholecystectomy. In patients of Child-Pugh class C, conservative or minimally invasive approaches should be used to treat complications of GSs.
© 2021 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ACLF, acute-on-chronic liver failure; CBD, common bile duct; CTP, Child-Pugh; Child-Pugh class; EPBD, Endoscopic papillary balloon dilatation; EST, endoscopic sphincterotomy; EUS, endoscopic ultrasound; FXR, farnesoid X receptors; GSs, Gallstones; HBV, hepatitis B virus; HCV, Hepatitis C virus; IR, insulin resistance; LC, laparoscopic cholecystectomy; MELD, Model for end-stage liver disease; NAFLD, non-alcoholic fatty liver disease; NS 5A, non-structural protein 5A; cirrhosis; gallstone; laparoscopic cholecystectomy

Year:  2021        PMID: 35535063      PMCID: PMC9077239          DOI: 10.1016/j.jceh.2021.09.011

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  97 in total

1.  Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors.

Authors:  Paola Loria; Amedeo Lonardo; Silvia Lombardini; Lucia Carulli; Annamaria Verrone; Dorval Ganazzi; Antonia Rudilosso; Roberto D'Amico; Marco Bertolotti; Nicola Carulli
Journal:  J Gastroenterol Hepatol       Date:  2005-08       Impact factor: 4.029

2.  Bile acid metabolism in cirrhosis. 3. Biliary lipid secretion in patients with cirrhosis and its relevance to gallstone formation.

Authors:  Z R Vlahcevic; T Yoshida; P Juttijudata; C C Bell; L Swell
Journal:  Gastroenterology       Date:  1973-02       Impact factor: 22.682

3.  The prevalence of gallstones in chronic liver disease is related to degree of liver dysfunction.

Authors:  A N Elzouki; S Nilsson; P Nilsson; H Verbaan; M Simanaitis; S Lindgren
Journal:  Hepatogastroenterology       Date:  1999 Sep-Oct

4.  Evidence of impaired gallbladder function in patients with liver cirrhosis by quantitative radionuclide cholescintigraphy.

Authors:  C H Kao; J F Hsieh; S C Tsai; Y J Ho; S D Chen
Journal:  Am J Gastroenterol       Date:  2000-05       Impact factor: 10.864

5.  Incidence of gallstone disease in Italy: results from a multicenter, population-based Italian study (the MICOL project).

Authors:  Davide Festi; Ada Dormi; Simona Capodicasa; Tommaso Staniscia; Adolfo-F Attili; Paola Loria; Paolo Pazzi; Giuseppe Mazzella; Claudia Sama; Enrico Roda; Antonio Colecchia
Journal:  World J Gastroenterol       Date:  2008-09-14       Impact factor: 5.742

6.  Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].

Authors:  Jason M Hui; Archana Sud; Geoffrey C Farrell; Priyanka Bandara; Karen Byth; James G Kench; Geoffrey W McCaughan; Jacob George
Journal:  Gastroenterology       Date:  2003-12       Impact factor: 22.682

7.  Hepatitis C virus infection is a risk factor for gallstone disease: a prospective hospital-based study of patients with chronic viral C hepatitis.

Authors:  M Acalovschi; C Buzas; C Radu; M Grigorescu
Journal:  J Viral Hepat       Date:  2009-05-26       Impact factor: 3.728

8.  HCV infection is a risk factor for gallstone disease in liver cirrhosis: an Italian epidemiological survey.

Authors:  T Stroffolini; E Sagnelli; A Mele; C Cottone; P L Almasio
Journal:  J Viral Hepat       Date:  2007-09       Impact factor: 3.728

9.  The prevalence and risk factors of gallstones in Korean patients with liver cirrhosis.

Authors:  Jae Hyun Park; Tae Nyeun Kim; Si Hyung Lee
Journal:  Hepatogastroenterology       Date:  2013-05

10.  Laparoscopic cholecystectomy in the cirrhotic patient: predictors of outcome.

Authors:  Ralph C Quillin; Justin M Burns; Jaime A Pineda; Dennis Hanseman; Steven M Rudich; Michael J Edwards; Amit D Tevar
Journal:  Surgery       Date:  2013-01-07       Impact factor: 3.982

View more
  1 in total

Review 1.  Surgical Risk Assessment in Patients with Chronic Liver Diseases.

Authors:  Shekhar S Jadaun; Sanjiv Saigal
Journal:  J Clin Exp Hepatol       Date:  2022-03-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.